Topical CBD for Musculoskeletal Pain

NCT ID: NCT05411913

Last Updated: 2022-06-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-01

Study Completion Date

2022-11-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Various OTC and CBD containing topicals are evaluated in a double blind survey. Each sample has a QR code that is to be scanned before applying. The QR code links to a survey form with application instructions and collects participant information and feedback.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Individuals are provided with a sample of topical substance to apply to a localized region of pain.
Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Everything is masked by QR code - participant and intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GoodFOR Pain

GoodFOR Pain is a FDA registered topical analgesic.

Intervention Type DRUG

Icy Hot

a FDA OTC registered topical analgesic.

Intervention Type DRUG

Tiger Balm

a FDA OTC registered topical analgesic

Intervention Type DRUG

Bengay

a FDA OTC registered topical analgesic.

Intervention Type DRUG

CBD Clinic Muscle and Joint Pain Relief Ointment

a non FDA registered topical analgesic.

Intervention Type DRUG

CBD FX CBD Muscle and Joint Cream: Cooling Formula

a non FDA registered topical analgesic.

Intervention Type DRUG

Essential Wholesale Muscle Gel

a non FDA registered topical analgesic.

Intervention Type DRUG

Extract Labs Muscle Cream

a non FDA registered topical analgesic.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* has Pain

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Apothyx, Co.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Daniel Charles McShan, PhD

Chief Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Topical-CBD-PAIN-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Massage Therapy for Chronic Low Back Pain
NCT01973010 COMPLETED PHASE2/PHASE3
Mechanisms of CBD for Chronic Pain
NCT04044729 COMPLETED EARLY_PHASE1
Effects of Thai Massage on EMG
NCT02067325 COMPLETED NA